<DOC>
	<DOCNO>NCT02826473</DOCNO>
	<brief_summary>Neurocognitive Disorder ( NCD ) affect 116'000 people Switzerland frequently unrecognized underdiagnosed . Because missed delayed diagnosis associate increase burden disease health Service Research prompt discussion diagnostic guideline screen program . Some argue screen NCD primary care optimal strategy increase recognition rate ; others consider test protocol implement hospital admission assessment justify . There distinct recommendation due lack empirical data benefit harm cognitive test yet . This trial strive fill gap provide information benefit , harm economic case routine cognitive test neurocognitive disorder high risk elective inpatient , Switzerland . The investigator hypothesize , cognitive test patient , compare patient cognitive test , high health-related quality life 12months ; low medical health care cost 18months .</brief_summary>
	<brief_title>Focused Cognitive Testing Inpatients</brief_title>
	<detailed_description />
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<criteria>Elective inpatient , live canton lucerne , high risk develop major neurocognitive disorder , living home Known mental disorder accord ICD10 , chapter V , exclude F32 &amp; F33 , patient terminal illness , patient intensive care unit oncology patient , adequate vision hearing , ability speak , write understand German , Informant , antidementia medication</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Dementia</keyword>
	<keyword>Dementia screening</keyword>
	<keyword>General Hospital</keyword>
	<keyword>Inpatients</keyword>
</DOC>